Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende, Elliott D. Crouser, Greg S. Martin, Timothy Albertson, Raquel R. Bartz, Scott C. Brakenridge, Matthew J. Delano, Pauline K. Park, Michael W. Donnino, Mark Tidswell, Florian B. Mayr, Derek C. Angus, Craig M. Coopersmith, Lyle L. Moldawer, Ian M. Catlett, Ihab G. Girgis, June Ye, Dennis M. Grasela

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab'. Together they form a unique fingerprint.

Medicine & Life Sciences